| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2007 | CN1297275C The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 01/31/2007 | CN1297274C Medical composition |
| 01/31/2007 | CN1297273C Pyrroloquinoline containing composition for enriching zinc and reducing plumbum |
| 01/31/2007 | CN1297272C New use of chlophenamine maleate |
| 01/31/2007 | CN1297271C Fat emulsion injection of bulleyaconitine A and its manufacturing method |
| 01/31/2007 | CN1297270C Ophthalmic composition comprising ascomycin |
| 01/31/2007 | CN1297269C Use of epothilone derivatives for the treatment of hyperparathyroidism |
| 01/31/2007 | CN1297268C Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 01/31/2007 | CN1297267C Medicinal composition containing tanshinon II A sodium sulfonate and its quality control method |
| 01/31/2007 | CN1297266C Stabilized ascorbic acid derivatives |
| 01/31/2007 | CN1297265C Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/31/2007 | CN1297264C Loselofen sodium injection and its preparation |
| 01/31/2007 | CN1297263C Calcium gluconate oral disintegrating tablet and its preparation process |
| 01/31/2007 | CN1297262C Compositions for lessening oxidative stress |
| 01/31/2007 | CN1297261C Fatty acyl acetaldehyde transfusion preparation and its preparing method |
| 01/31/2007 | CN1297260C Fatty acyl acetaldehyde powder projection and its preparing method |
| 01/31/2007 | CN1297259C Total diterpene phenol originated from rosemary, its preparation method and use |
| 01/31/2007 | CN1297258C EPO D+5-fu/gemcitabine |
| 01/31/2007 | CN1297257C Tulobuterol containing pressure-sensitive adhesive, transdermal paster, and its preparing method and use |
| 01/31/2007 | CN1297254C Drop pills containing bear gall and tendril-leaved fritillary bulb and preparation method thereof |
| 01/31/2007 | CN1297252C Concentrated solution of non-foaming ammonium compounds and method of use |
| 01/31/2007 | CN1297251C Hot pepper gel for treating rheumatism |
| 01/31/2007 | CN1297217C Application of Palatinose for pereparing brain Alpha wave emitting enhancing agent and food |
| 01/30/2007 | US7169953 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169948 antitumor and antiproliferative agents; inert in acqueous solution at both pH 5.5. and 7.4 |
| 01/30/2007 | US7169942 Cannabinoid derivatives, methods of making, and use thereof |
| 01/30/2007 | US7169940 Compounds and pharmaceutical compositions comprising same |
| 01/30/2007 | US7169936 Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| 01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| 01/30/2007 | US7169931 Cell differentiation, cell proliferation |
| 01/30/2007 | US7169930 Analogs of epothilone |
| 01/30/2007 | US7169929 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169819 A pharmaceutical formulation for parenteral delivery, comprising a retinide such as fenretinide in combination with a solvent (an alcohol) and a alkoxylate castor oil, capable of dispersing or dissolving the retinide; anticancer agent |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169816 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 01/30/2007 | US7169815 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 01/30/2007 | US7169814 Guanidinium transport reagents and conjugates |
| 01/30/2007 | US7169813 metabolite of fenretinide; 4-oxo-N-(4-hydroxyphenyl) retinamide (4-oxo-4-HPR); antiproliferative; antitumor; ovarian carcinoma, breast tumor, neuroblastoma; overcomes 4-HPR resistance |
| 01/30/2007 | US7169812 Insertion catheter into cerebrospinal fluid; administering drug, preparing an injectable composition comprising gabapentin and a pharmaceutically acceptable vehicle; andheating the injectable composition at greater than or equal to about 105 degrees C |
| 01/30/2007 | US7169811 Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne |
| 01/30/2007 | US7169810 Phenylalkyleneoxybenzene derivatives; insulin resistance; diabetes, obesity, dyslipidemia treatment; hypotensive agents |
| 01/30/2007 | US7169809 Reducing risk of thrombotic cardiovascular events such as stroke, myocardial ischemia, myocardial infarction, angina pectoris, and transient ischemic attack; side effect reduction |
| 01/30/2007 | US7169808 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity |
| 01/30/2007 | US7169807 For therapy of asthma, dysmenorrhea, osteoporosis, bone disorders, constipation, renal disorders, sexual dysfunction, baldness, acute hepatitis, bronchitis, burn, chronic obstructive respiratory diseases, Crohn's disease, digestive ulcer, hemophagous syndrome, hepatopathy, hypercytokinemia at dialysis |
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169805 Captopril derivatives |
| 01/30/2007 | US7169804 Bactericides; veterinary medicine |
| 01/30/2007 | US7169803 For therapy of disorders which are responsive to the opening of potassium channels, for therapy of ischemia, stroke, convulsions, epilepsy, asthma, irritable bowel syndrome, migraine, traumatic brain injury, elevated intracranial pressure, spinal cord injury, carbon monoxide poisoning, sexual dysfunction |
| 01/30/2007 | US7169802 Fused pyrrolocarbazoles |
| 01/30/2007 | US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 01/30/2007 | US7169800 For cancer therapy |
| 01/30/2007 | US7169799 Process for producing crystal |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169797 Protein-tyrosine phosphatase inhibitors and uses thereof |
| 01/30/2007 | US7169796 Polyarylcarboxamides useful as lipid lowering agents |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169794 Oxidation of a chemical intermediate |
| 01/30/2007 | US7169793 An amorphous form of esomeprazole, and dosage forms thereof; enantioselective process involves forming a transition metal complex; treating gastric disorders such as ulcers |
| 01/30/2007 | US7169792 Method of treating bacterial infections using gemifloxacin or a salt thereof and a β-lactam antibiotic |
| 01/30/2007 | US7169791 Inhibitors of tyrosine kinases |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169789 Quinoline derivatives and quinazoline derivatives |
| 01/30/2007 | US7169788 controlling signal transduction; angiogenesis inhibitor; anticancer agents; antitumor agents; cardiovascular disorders; vision defects; antiinflammatory agents |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169786 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 01/30/2007 | US7169784 Medical devices employing triazine compounds and compositions thereof |
| 01/30/2007 | US7169783 For regulation of growth of neurons in the Central Nervous System |
| 01/30/2007 | US7169782 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2007 | US7169781 Such as 2-(2,6-dichlorophenyl)-4-(3-chlorophenyl)-5-(2-methylthiopyrimidin-4-yl)-N H-imidazole as anticarcinogenic agent |
| 01/30/2007 | US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169775 Amino methyl imidazoles as C5a receptor modulators |
| 01/30/2007 | US7169774 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
| 01/30/2007 | US7169773 Compounds |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | US7169771 Thiazolyl-based compounds useful as kinase inhibitors |
| 01/30/2007 | US7169770 Method of enhancing reproductive performance in sows |
| 01/30/2007 | US7169769 17α-hydroxy-14β-steroids with hormonal effect |
| 01/30/2007 | US7169768 Method of decreasing atherosclerosis and its complications |
| 01/30/2007 | US7169767 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/30/2007 | US7169766 Administering nucleoside, or prodrug thereof; viricides |
| 01/30/2007 | US7169765 Acyl derivatives of 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, and 2'-deoxythymidine; for treating or preventing radiation, mutagen and sunlight-induced biological damage, and improving wound healing and tissue repair |
| 01/30/2007 | US7169764 Promoter for smooth muscle cell expression |
| 01/30/2007 | US7169763 Cytochrome P450 3A inhibitors and enhancers |
| 01/30/2007 | US7169762 Prepared by reacting a culture solution obtained by preliminarily culturing basidiomycetes with a reaction mixture obtained by reacting bran extracts with an enzyme; use as food, medicine and feedstuff utilizing the physiological activity of the substance; |
| 01/30/2007 | US7169761 Azulene derivatives and salts thereof |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
| 01/30/2007 | US7169750 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 01/30/2007 | US7169746 For effecting mental control through psycho-sedation or psycho-stimulation |
| 01/30/2007 | US7169607 In vivo induction for enhanced function of isolated hepatocytes |